SCAI 2023 Scientific Sessions

Review the latest interventional cardiology research, clinical guidance, and insights from lead cardiologists in the field.

Ticagrelor monotherapy is linked with similar rates of recurrent coronary revascularization compared with standard therapy.

Dr. George D. Dangas, about a study he led which analyzed the predictive value of the thrombotic risk criteria.

Dr. Tanvir K. Bajwa talks about the FX TAVR system, designed to improve ease of use in coronary access.

Pulmonary embolism patients treated with mechanical thrombectomy have improved outcomes and quality of life.

Marijuana users incur more than three times the risk of developing peripheral artery disease.

The novel Supira 10F system is a safe and effective percutaneous ventricular assist device for high-risk PCI.